Abstract
Chitosan is a natural polysaccharide prepared by the N-deacetylation of chitin. In this paper we have reviewed the methods of preparation of chitosan-based nanoparticles and their pharmaceutical applications. There are five methods of their preparations: emulsion cross-linking, emulsion-droplet coalescence, ionic gelation, reverse micellar method and chemically modified chitosan method. Chitosan nanoparticles are used as carriers for low molecular weight drug, vaccines and DNA. Releasing characteristics, biodistribution and applications are also summarized.
Similar content being viewed by others
References
Chen, X. G., C. M. Lee, and H. J. Park, 2003. O/W emulsification for the self-aggregation and nanoparticle formation of linoleic acids modified chitosan in the aqueous system. J. Agric. Food Chem., 51: 3135–3139.
Christopher, P. L., and S. L. Philip., 2001. Folate-mediated targeting: from diagnostics to drug and gene delivery. Drug Discov. Today, 6: 44–51.
Corsi, K., F. Chellat, L. Yahia, and J. C. Fernandes, 2003. Mesenchymal stem cells, MG63 and HEK293 transfection using chitosan-DNA nanoparticles. Biomaterials, 24: 1255–1264.
Cui, Z., and R. J. Mumper, 2001. Chitosan-based nanoparticles for topical genetic immunization. J. Control. Release, 75: 409–419.
Dyer, A. M., M. Hinchcliffe, P. Watts, J. Castile, I. Jabbal-Gill, et al., 2002. Nasal delivery of insulin using novel chitosan based formulations: a comparative study in two animal models between simple chitosan formulations and chitosan nanoparticles. Pharma. Res., 19: 998–1008.
Erbacher, P., S. Zou, T. Bettinger, A. M. Steffan, and J. S. Remy, 1998. Chitosan-based vector/DNA complexes for gene delivery: biophysical characteristics and transfection ability. Pharma. Res., 159: 1332–1339.
Felt, O., P. Buri, and R. Gurny, 1998. Chitosan: a unique polysaccharide for drug delivery. Drug Devel. Indus. Pharm., 24: 979–993.
Fernandez-Urrusuno, R., P. Cavlo, C. Remunan-Lopez, J. L. Vila-Jato, and M. J. Alonso, 1999. Enhancement of nasal absorption of insulin using chitosan nanoparticles. Pharm. Res., 16: 1576–1581.
Gao, S., J. Chen, X. Xu, Z. Ding, Y.H. Yang, et al., 2003. Galactosylated low molecular weight chitosan as DNA carrier for hepatocyte-targeting. Int. J. Clin. Pharm. Res., 255: 57–68.
Illum, L., I. Jabbal-Gill, M. Hinchcliffe, A. N. Fisher, and S. S. Davis, 2001. Chitosan as a novel nasal delivery system for vaccines. Adv. Drug Deliv. Rev., 51: 81–96.
Janes, K. A., P. Calvo, and M. J. Alonso, 2001a. Polysaccharide colloidal particles as delivery systems for macromolecules. Adv. Drug Deliv. Rev., 47: 83–97.
Janes, K. A., M. P. Fresneau, M. Ana, F. Angels, and J. A. Marıa, 2001b. Chitosan nanoparticles as delivery systems for doxorubicin. J. Control. Release, 73: 255–267.
Jong, H. K., S. K. Yoo, K. W. Sung, J. H. Park, K. Kim, et al., 2006. Hydrophobically modified glycol chitosan nanoparticles as carriers for paclitaxel. J. Control. Release, 111: 228–234.
Kataoka, K., T. Matsumoto, M. Tokohama, T. Okano, Y. Sakurai, et al., 2000. Doxorubicin-loaded poly(ethylene glycol)-poly(b-benzyl-L-aspartate) copolymer micelles: their pharmaceutical characteristics and biological significance. J. Control. Release, 64: 143–153.
Kim, T. H., I. K. Park, J. W. Nah, Y. J. Choi and C. S. Cho, 2004. Galactosylated chitosan/DNA nanoparticles prepared using water-soluble chitosan as a gene carrier. Biomaterials, 25: 3 783–3 792.
Lee, K. Y., J. H. Kim, I. C. Kwon, and S. Y. Jeong, 2001. Self-aggregates of deoxycholic acid-modified chitosan as a novel carrier of adriamycin. Coll. Polym. Sci., 278: 1216–1219.
Liu, C. G., K. G. H. Desai, X. G. Chen, and H. J. Park, 2005a. Linolenic Acid-Modified Chitosan for Formation of Self-Assembled Nanoparticles. J. Agric. Food Chem., 53: 437–441.
Liu, C. G., X. G. Chen, and H. J. Park, 2005b. Self-assembled nanoparticles based on linoleic-acid modified chitosan: Stability and adsorption of trypsin. Carbohyd. Polym., 62: 293–298.
MacLaughlin, F. C., R. J. Mumper, J. Wang, J. M. Tagliaferri, I. Gill, et al., 1998. Chitosan and depolymerized chitosan oligomers as condensing carriers for in vivo plasmid delivery. J. Control. Release, 56: 259–272.
Mao, H. Q., K. Roy, V. L. Troung-Le, K. Y. Lim, Y. Wang, et al., 1997. DNA-chitosan nanospheres: derivitization and storage stability. P. Int. Symp. Control. Release. Bioact. Mater., 24: 671–672.
Mao, H. Q., K. Roy, V. L. Troung-Le, K. A. Janes, K. Y. Lim, et al., 2001. Chitosan DNA nanoparticles as gene delivery carriers: synthesis, characterization and transfection efficiency. J. Control. Release, 70: 399–421.
Mitra, S., U. Gaur, P. C. Ghosh, and A. N. Maitra, 2001. Tumor targeted delivery of encapsulated dextran-doxorubicin conjugate using chitosan nanoparticles as carrier. J. Control. Release, 74: 317–323.
Murata, J., Y. Ohya and T. Ouchi, 1996. Possibility of application of quaternary chitosan having pendant galactose residues as gene delivery tool. Carbohyd. Polym., 29: 69–74.
Ohya, Y., M. Shiratani, H. Kobayashi, and T. Ouchi, 1994. Release behavior of 5-fluorouracil from chitosan-gel nanospheres immobilizing 5-fluorouracil coated with polysaccharides and their cell specific cytotoxicity. Pure Appl. Chem., A31: 629–642.
Park, I. K., T. H. Kim, Y. H. Park, B. A. Shin, E. S. Choi, et al., 2001. Galactosylated chitosan-graft-poly (ethylene glycol) as hepatocyte-targeting DNA carrier. J. Control. Release, 76: 349–362.
Park, J. H., S. Kwon, M. Lee, H. Chung, H. K. Ji, et al., 2006, Self-assembled nanoparticles based on glycol chitosan bearing hydrophobic moieties as carriers for doxorubicin: In vivo biodistribution and anti-tumor activity. Biomaterials, 27: 119–126.
Richardson, S. C. W., H. V. J. Kolbe, and R. Dunean, 1999. Potential of low molecular mass chitosan as a DNA delivery system: biocompatibility, body distribution and ability to complex and protect DNA. Int. J. Pharm., 178: 231–243.
Roy, K., H. Q. Mao, and K. W. Leong, 1997. DNA-chitosan nanosperes: transfection effiency and cellar uptake. Preoceeding Int. Symp. Control. Release. Bioact. Mater., 24: 673–674.
Sania, M., C. Yan, W. Francoise, S. Qin, L. Patrick, et al., 2006. Characterization of folate-chitosan-DNA nanoparticles for gene therapy. Biomaterials, 27: 2060–2065.
Sato, T., T. Ishii and Y. Okahata, 2001. In vitro gene delivery mediated by chitosan. Effect of pH, serum, and molecular mass of chitosan on the transfection efficiency. Biomaterials, 22: 2075–2080.
Se, K. K., and R. Niranjan, 2005. Enzymatic production and biological activities of chitosan oligosaccharides (COS): A review. Carbohyd. Polym., 62: 357–368.
Sevda, S., and S. J. McClureb, 2004. Potential applications of chitosan in veterinary medicine. Adv. Drug Deliver. Rev., 56: 1467–1480.
Son, Y. J., J. S. Jang, Y. W. Cho, H. Chung, R. W. Park, et al., 2003. Biodistribution and anti-tumor efficacy of doxorubicin loaded glycol-chitosan nanoaggregates by EPR effect. J. Control. Release, 91: 135–145.
Sunil, A. A., N. M. Nadagouda, and M. Tejraj, 2004. Recent advances on chitosan-based micro-and nanoparticles in drug delivery. J. Control. Release, 100: 5–28.
Takeuchi, H., H. Yamamoto, and Y. Kawashima, 2001. Mucoadhesive nanoparticle systems for peptide drug delivery. Adv. Drug Deliver. Rev., 47: 39–54.
Thanou, M., B. I. Florea, M. Geldof, H. E. Junginger and G Borchard, 2002. Quaternized chitosan oligomers as novel gene delivery vectors in epithelial cell lines. Biomaterials, 23: 153–159.
Tokumitsu, H., H. Ichikawa, and Y. Fukumori, 1999. Chitosan-gadopentetic acid complex nanoparticles for gadolinium neutron capture therapy of cancer: preparation by novel emulsiondroplet coalescence technique and characterization. Pharm. Res., 16: 1830–1835.
Uchegbu, I. F., A. G. Schatzlein, L. Tetley, A. I. Gray, J. Sludden, et al., 1998. Polymeric chitosan-based vesicles for drug delivery. J. Pharm. Pharmacol., 50: 453–458.
Van der Lubben, I. M., J. C. Verhoef, G. Borchard, and H. E. Junginger, 2001. Chitosan and its derivatives in mucosal drug and vaccine delivery. Eur. J. Pharm. Sci., 14: 201–207.
Van der Lubben, I. M., J. C. Verhoef, G. Borchard, and H. E. Junginger, 2001. Chitosan for mucosal vaccination. Adv. Drug Deliver. Rev., 52: 139–144.
Vila, A., A. Sa–nchez, K. Janes, I. Behrens, T. Kissel, et al., 2004. Low molecular weight chitosan nanoparticles as new carriers for nasal vaccine delivery in mice. Eur. J. Pharm. Biopharm., 57: 123–131.
Wang, S., J. Luo, D. A. Lantrip, D. J. Waters, C. J. Mathias, et al., 1997. Design and synthesis of DTPA-folate for use as a tumortargeted radiopharmaceutical. Bioconjugate Chem., 8: 673–679.
Xu, Y. M., Y. M. Du, R. H. Huang, and L. P. Gao, 2003. Preparation and modification of N-(2-hydroxyl) propyl-3-trimethyl ammonium chitosan chloride nanoparticle as a protein carrier. Biomaterials, 24: 5015–5022.
Yokohama, M., S. Fukushima, R. Uehara, K. Okamoto, K. Kataoka, et al., 1998. Characterization of physical entrapment and chemical conjugation of adriamycin in polymeric micelles and their design for in vivo delivery to a solid tumor. J. Control. Release, 50: 79–92.
Yoo, H. S., and T. G. Park, 2004a. Folate receptor targeted biodegradable polymeric doxorubicin micelles. J. Control. Release, 96: 273–283.
Yoo, H. S., and T. G. Park, 2004b. Folate-receptor-targeted delivery of doxorubicin nano-aggregates stabilized by doxorubicin-PEG-folate conjugate. J. Control. Release, 100: 247–256.
Yoo, H. S., J. E. Lee, H. Chung, I. C. Kwon, and S. Y. Jeong, 2005. Self-assembled nanoparticles containing hydrophobically modified glycol chitosan for gene delivery. J. Control. Release, 103: 235–243.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Liu, C., Tan, Y., Liu, C. et al. Preparations, characterizations and applications of chitosan-based nanoparticles. J Ocean Univ. China 6, 237–243 (2007). https://doi.org/10.1007/s11802-007-0237-9
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s11802-007-0237-9